3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))

C144H113N25Pt4 — CID 157255373

IUPAC3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))
SMILESCC(C)c1ccccc1-n1cnc(-c2[c-]c(N(c3ccccc3)c3cccc(CN4C=CN(c5ccccc5)[CH-]4)n3)ccc2)c1.Cn1ccnc1N(c1[c-]c(N(c2[c-]c(-c3cn(-c4ccccc4)cn3)ccc2)c2ccccc2)ccc1)c1ccccc1.Cn1ccnc1N(c1[c-]c(N(c2[c-]c(-c3cn(-c4ccncc4)cn3)ccc2)c2ccccc2)ccc1)c1ccccc1.Cn1cnc(-c2[c-]c(N(c3[c-]c4c(cc3)c3ccccc3n4-c3nccn3C)c3ccccc3)ccc2)c1.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C39H34N6.C37H28N6.C36H27N7.C32H24N6.4Pt/c1-30(2)36-20-9-10-21-38(36)44-27-37(40-28-44)31-13-11-19-35(25-31)45(34-17-7-4-8-18-34)39-22-12-14-32(41-39)26-42-23-24-43(29-42)33-15-5-3-6-16-33;1-40-24-23-38-37(40)43(32-18-9-4-10-19-32)35-22-12-21-34(26-35)42(31-16-7-3-8-17-31)33-20-11-13-29(25-33)36-27-41(28-39-36)30-14-5-2-6-15-30;1-40-23-22-38-36(40)43(31-13-6-3-7-14-31)34-17-9-16-33(25-34)42(30-11-4-2-5-12-30)32-15-8-10-28(24-32)35-26-41(27-39-35)29-18-20-37-21-19-29;1-35-21-29(34-22-35)23-9-8-12-25(19-23)37(24-10-4-3-5-11-24)26-15-16-28-27-13-6-7-14-30(27)38(31(28)20-26)32-33-17-18-36(32)2;;;;/h3-24,27-30H,26H2,1-2H3;2-24,27-28H,1H3;2-23,26-27H,1H3;3-18,21-22H,1-2H3;;;;/q4*-2;4*+2
InChIKeySEWBZMAAUUTEQW-UHFFFAOYSA-N
MW2973.97 g/mol
LogP33.24
Rot. Bonds30

About 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))

3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+)) (PubChem CID 157255373) has the molecular formula C144H113N25Pt4 and a molecular weight of 2973.97 g/mol. Its IUPAC name is 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+)).

Molecular Properties

Compound Name3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))
PubChem CID157255373
Molecular FormulaC144H113N25Pt4
Molecular Weight2973.97 g/mol
Exact Mass2971.82
IUPAC Name3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))
SMILESCC(C)c1ccccc1-n1cnc(-c2[c-]c(N(c3ccccc3)c3cccc(CN4C=CN(c5ccccc5)[CH-]4)n3)ccc2)c1.Cn1ccnc1N(c1[c-]c(N(c2[c-]c(-c3cn(-c4ccccc4)cn3)ccc2)c2ccccc2)ccc1)c1ccccc1.Cn1ccnc1N(c1[c-]c(N(c2[c-]c(-c3cn(-c4ccncc4)cn3)ccc2)c2ccccc2)ccc1)c1ccccc1.Cn1cnc(-c2[c-]c(N(c3[c-]c4c(cc3)c3ccccc3n4-c3nccn3C)c3ccccc3)ccc2)c1.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C39H34N6.C37H28N6.C36H27N7.C32H24N6.4Pt/c1-30(2)36-20-9-10-21-38(36)44-27-37(40-28-44)31-13-11-19-35(25-31)45(34-17-7-4-8-18-34)39-22-12-14-32(41-39)26-42-23-24-43(29-42)33-15-5-3-6-16-33;1-40-24-23-38-37(40)43(32-18-9-4-10-19-32)35-22-12-21-34(26-35)42(31-16-7-3-8-17-31)33-20-11-13-29(25-33)36-27-41(28-39-36)30-14-5-2-6-15-30;1-40-23-22-38-36(40)43(31-13-6-3-7-14-31)34-17-9-16-33(25-34)42(30-11-4-2-5-12-30)32-15-8-10-28(24-32)35-26-41(27-39-35)29-18-20-37-21-19-29;1-35-21-29(34-22-35)23-9-8-12-25(19-23)37(24-10-4-3-5-11-24)26-15-16-28-27-13-6-7-14-30(27)38(31(28)20-26)32-33-17-18-36(32)2;;;;/h3-24,27-30H,26H2,1-2H3;2-24,27-28H,1H3;2-23,26-27H,1H3;3-18,21-22H,1-2H3;;;;/q4*-2;4*+2
InChIKeySEWBZMAAUUTEQW-UHFFFAOYSA-N
XLogP33.24
TPSA181.37 Ų
H-Bond Donors
H-Bond Acceptors25
Rotatable Bonds30
Heavy Atoms173
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002973.97
LogP ≤ 533.24
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

9-[4-[2,6-di(propan-2-yl)phenyl]-2-pyridinyl]-N-phenyl-N-[3-[3-(trideuteriomethyl)-2H-benzimidazol-1-yl]benzene-2-id-1-yl]-1H-carbazol-1-id-2-amine;platinum(2+)
CID 167382907
N-[3-(3-tert-butyl-2H-benzimidazol-1-yl)benzene-2-id-1-yl]-N-phenyl-9-(4-propan-2-yl-2-pyridinyl)-1H-carbazol-1-id-2-amine;platinum(2+)
CID 167381741
N-phenyl-N-[3-(3-propan-2-yl-2H-benzimidazol-1-yl)benzene-2-id-1-yl]-9-[4-(2-propan-2-ylphenyl)-2-pyridinyl]-1H-carbazol-1-id-2-amine;platinum(2+)
CID 167382386
N-phenyl-N-[3-(3-phenyl-2H-benzimidazol-1-yl)benzene-2-id-1-yl]-9-(4-phenyl-2-pyridinyl)-1H-carbazol-1-id-2-amine;platinum(2+)
CID 167382684
N-phenyl-N-[3-(3-phenyl-2H-benzimidazol-1-yl)benzene-2-id-1-yl]-9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-amine;platinum(2+)
CID 167382811
N-phenyl-N-[3-(3-phenyl-2H-benzimidazol-1-yl)benzene-2-id-1-yl]-9-[4-(2-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-id-2-amine;platinum(2+)
CID 167382622
N-(2,6-diphenylphenyl)-N-[3-(3-phenyl-2H-benzimidazol-1-yl)benzene-2-id-1-yl]-9-(4-propan-2-yl-2-pyridinyl)-1H-carbazol-1-id-2-amine;platinum(2+)
CID 155623092
9-(4-tert-butyl-2-pyridinyl)-N-[3-[3-(2,3,4,5,6-pentamethylphenyl)-2H-imidazol-2-id-1-yl]benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;platinum
CID 155652147
N-[3-[3-(3-tert-butylphenyl)-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]-9-(4-tert-butyl-2-pyridinyl)-N-phenyl-1H-carbazol-1-id-2-amine;platinum
CID 155651161
N-[3-(1-methyl-2,1,3-benzoxadiazol-2-ium-3-yl)benzene-2-id-1-yl]-9-(4-methyl-2-pyridinyl)-N-phenyl-1H-carbazol-1-id-2-amine;platinum
CID 162465237
N-phenyl-9-(4-phenyl-2-pyridinyl)-N-[3-[3-(trideuteriomethyl)-2H-benzimidazol-1-yl]benzene-2-id-1-yl]-1H-carbazol-1-id-2-amine;platinum(2+)
CID 167382070
acetylene;N-phenyl-9-pyridin-2-yl-N-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-1H-carbazol-1-id-2-amine;platinum(2+)
CID 163770103

Frequently Asked Questions

What is the IUPAC name of 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))?
The IUPAC name of 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+)) (CID 157255373) is 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+)).
What is the SMILES notation for 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))?
The canonical SMILES for 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+)) is CC(C)c1ccccc1-n1cnc(-c2[c-]c(N(c3ccccc3)c3cccc(CN4C=CN(c5ccccc5)[CH-]4)n3)ccc2)c1.Cn1ccnc1N(c1[c-]c(N(c2[c-]c(-c3cn(-c4ccccc4)cn3)ccc2)c2ccccc2)ccc1)c1ccccc1.Cn1ccnc1N(c1[c-]c(N(c2[c-]c(-c3cn(-c4ccncc4)cn3)ccc2)c2ccccc2)ccc1)c1ccccc1.Cn1cnc(-c2[c-]c(N(c3[c-]c4c(cc3)c3ccccc3n4-c3nccn3C)c3ccccc3)ccc2)c1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))?
The InChIKey is SEWBZMAAUUTEQW-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H34N6.C37H28N6.C36H27N7.C32H24N6.4Pt/c1-30(2)36-20-9-10-21-38(36)44-27-37(40-28-44)31-13-11-19-35(25-31)45(34-17-7-4-8-18-34)39-22-12-14-32(41-39)26-42-23-24-43(29-42)33-15-5-3-6-16-33;1-40-24-23-38-37(40)43(32-18-9-4-10-19-32)35-22-12-21-34(26-35)42(31-16-7-3-8-17-31)33-20-11-13-29(25-33)36-27-41(28-39-36)30-14-5-2-6-15-30;1-40-23-22-38-36(40)43(31-13-6-3-7-14-31)34-17-9-16-33(25-34)42(30-11-4-2-5-12-30)32-15-8-10-28(24-32)35-26-41(27-39-35)29-18-20-37-21-19-29;1-35-21-29(34-22-35)23-9-8-12-25(19-23)37(24-10-4-3-5-11-24)26-15-16-28-27-13-6-7-14-30(27)38(31(28)20-26)32-33-17-18-36(32)2;;;;/h3-24,27-30H,26H2,1-2H3;2-24,27-28H,1H3;2-23,26-27H,1H3;3-18,21-22H,1-2H3;;;;/q4*-2;4*+2.
What are the key properties of 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+))?
3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+)) has a molecular weight of 2973.97 g/mol, XLogP of 33.24, 30 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-phenylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;3-N-(1-methylimidazol-2-yl)-1-N,3-N-diphenyl-1-N-[3-(1-pyridin-4-ylimidazol-4-yl)benzene-2-id-1-yl]benzene-2-ide-1,3-diamine;9-(1-methylimidazol-2-yl)-N-[3-(1-methylimidazol-4-yl)benzene-2-id-1-yl]-N-phenyl-1H-carbazol-1-id-2-amine;N-phenyl-6-[(3-phenyl-2H-imidazol-2-id-1-yl)methyl]-N-[3-[1-(2-propan-2-ylphenyl)imidazol-4-yl]benzene-2-id-1-yl]pyridin-2-amine;tetrakis(platinum(2+)) is sourced from PubChem (CID 157255373), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).